Jacques M. Bonneterre

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer.

Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer.

Journal: Neuro-oncology

Published: October 23, 2019

French recommendations on strategies for preventing and treating osteoporosis induced by adjuvant breast cancer therapies.

French recommendations on strategies for preventing and treating osteoporosis induced by adjuvant breast cancer therapies.

Journal: Joint bone spine

Published: June 12, 2019

A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer.

A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer.

Journal: Breast cancer research : BCR

Published: January 29, 2019

Should a Multigene Signature be Used in all Luminal Early Breast Cancers.

Should a Multigene Signature be Used in all Luminal Early Breast Cancers.

Journal: Frontiers in oncology

Published: January 13, 2019

Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1.

Safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive advanced breast cancer: Primary results from the KAMILLA study cohort 1.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 05, 2018

French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation.

French recommendations for osteoporosis prevention and treatment in patients with prostate cancer treated by androgen deprivation.

Journal: Joint bone spine

Published: July 20, 2018

Chemical meningitis related to intra-CSF liposomal cytarabine.

Chemical meningitis related to intra-CSF liposomal cytarabine.

Journal: CNS oncology

Published: October 24, 2017

Neuroendocrine tumors of the breast: Myth or reality? A systematic review

Neuroendocrine tumors of the breast: Myth or reality? A systematic review

Journal: Bulletin du cancer

Published: September 25, 2017

Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.

Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 03, 2017

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.

Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.

Journal: PloS one

Published: July 23, 2017

Longitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patients.

Longitudinal serum metabolomics evaluation of trastuzumab and everolimus combination as pre-operative treatment for HER-2 positive breast cancer patients.

Journal: Oncotarget

Published: April 04, 2017

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab.

Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: February 09, 2017

Showing 1-12 of 57

Last Updated: 09/26/2026